India's largest maker of Ethyl Acetate and Diketene derivatives, serving pharma, agro, packaging and specialty industries.
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 45 | 53 | 53 | 53 | 55 | 55 | 55 | 55 |
| Reserves | 382 | 982 | 1.2k | 1.4k | 1.7k | 1.9k | 1.9k | 1.9k |
| Borrowings | 159 | 149 | 139 | 406 | 143 | 258 | 334 | 543 |
| Other Liabilities | 484 | 654 | 825 | 595 | 887 | 880 | 933 | 915 |
| Total Liabilities | 1.1k | 1.8k | 2.3k | 2.4k | 2.8k | 3.0k | 3.2k | 3.4k |
| AssetsFixed Assets | 338 | 325 | 394 | 715 | 879 | 1.2k | 1.4k | 1.5k |
| CWIP | 67 | 148 | 374 | 447 | 444 | 398 | 462 | 652 |
| Investments | 0 | 3 | 5 | 23 | 126 | 148 | 63 | 37 |
| Other Assets | 664 | 1.4k | 1.5k | 1.2k | 1.4k | 1.3k | 1.2k | 1.3k |
| Total Assets | 1.1k | 1.8k | 2.3k | 2.4k | 2.8k | 3.0k | 3.2k | 3.4k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 188 | 196 | 106 | 46 | 199 | 561 | 108 | 175 |
| Cash from Investing | -123 | -56 | -641 | 95 | -384 | -490 | -268 | -404 |
| Cash from Financing | -63 | -123 | 527 | -124 | 232 | -42 | 90 | 247 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 90 | 118 | -10 | -243 | -277 | 314 | -286 | -427 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (58.5×) and current (59.8×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At -14% growth and a 58× exit, ₹172 only delivers your return if you pay ₹30. The price is currently baking in 18% growth.
EPS grows -14%/yr for 5 years, then fades to 6% over 2, exits at 58×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | -14.0% | 2.47 |
| FY28 | -14.0% | 2.12 |
| FY29 | -14.0% | 1.83 |
| FY30 | -14.0% | 1.57 |
| FY31 | -14.0% | 1.35 |
| FY32 | -4.0% ·fade | 1.30 |
| FY33 | 6.0% ·fade | 1.37 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.